LAT-8881

N/A

Report date: 2025/05/03 20:00:05
NME

Base Information

Drug NameLAT-8881
Drug Alias NameAOD-9604LAT-8881
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsDiabetic peripheral neuropathyRadiculopathyNeuralgia, Postherpetic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMetabolic Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesLateral Pharma Pty Ltd
Inactive CompaniesN/A
Active IndicationsRadiculopathy
Inactive IndicationsDiabetic peripheral neuropathyNeuralgia, PostherpeticNeuralgia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A